• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. TRULIANT TIB IMP CR INS STD SZ 3.5, 9 MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. TRULIANT TIB IMP CR INS STD SZ 3.5, 9 MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED Back to Search Results
Model Number TRULIANT TIB IMP CR INS STD SZ 3.5, 9 MM
Medical Device Problem Codes Naturally Worn (2988); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Failure of Implant (1924); Pain (1994); Discomfort (2330); Swelling/ Edema (4577)
Date of Event 01/09/2024
Type of Reportable Event Serious Injury
Event or Problem Description
As reported, the 61 y/o female patient had an original bilateral tka procedure with exactech implants.The patient presented back to surgeon's office with complaints of their tka's and known recalled polyethylene implants.The patient already underwent a right tka revision poly swap and is now having the left tka poly swap.The patient was scheduled for a left knee revision possible poly swap and patella resurfacing.Patient was revised to trulaint crc tiabial insert sz 3.5, mm and optetrak 3 peg patella cemented mm 32.The patient left the or stable.Sales rep was unable to obtain x-rays or photos.
 
Additional Manufacturer Narrative
Additional information, including the product investigation, will be submitted within 30 days of receipt.
 
Additional Manufacturer Narrative
The reason for the revision reported cannot be confirmed from the information provided but may be the result of prosthesis wear or due to inclusion of the polyethylene in the packaging recall.However, the reported prosthesis wear could not be confirmed and potential contributions of user or patient-related considerations to the event could not be assessed as the devices were not available for evaluation and no images, radiographs, or relevant clinical information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRULIANT TIB IMP CR INS STD SZ 3.5, 9 MM
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer Contact
miguel soza
MDR Report Key18651423
Report Number1038671-2024-00162
Device Sequence Number8276216
Product Code JWH
UDI-Device Identifier10885862306425
UDI-Public10885862306425
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
K152170
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2024
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 10/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/17/2026
Device Model NumberTRULIANT TIB IMP CR INS STD SZ 3.5, 9 MM
Device Catalogue Number02-022-47-3509
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/10/2024
Supplement Date Received by Manufacturer11/23/2024
Initial Report FDA Received Date02/06/2024
Supplement Report FDA Received Date10/24/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured01/17/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-0023-2022
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
TRULIANT FEMORAL CR POROUS SZ3.5 LEFT; TRULIANT TIBIAL TRAY POROUS SZ 3.5F/3.5T
Outcome Attributed to Adverse Event Required Intervention;
Patient Age61 YR
Patient SexFemale
Patient Weight103 KG
-
-